drug costs
The impact of dementia on drug costs in older people: results from the SNAC study
9
Influence of subcutaneous specific immunotherapy on drug costs in children sufferingfrom allergic asthma
8
Long-term drug costs per life-month gained associated with first-line treatments for unresectable or metastatic melanoma
9
Controlling Excessive Off-Label Medicare Drug Costs Through the False Claims Act
45
Transcutaneous Electrical Nerve Stimulation (TENS) in the Immediate Postoperative Period Following Proximal Femoral Fractures Reduces Drug Costs
9
Physician adherence to hypertension treatment guidelines and drug acquisition costs of antihypertensive drugs at the cardiac clinic: a pilot study
8
Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment – a review
13
Rising medication costs for patients with neurologic disordersAbout medication costs
5
Non adherence to drug therapy and drug acquisition costs in a national population a patient based register study
11
Social Security Administration. What You Need To Know About Extra Help With Medicare Prescription Drug Plan Costs
31
Costs analysis at meat manufacturer Traditional costs accounting
63
The unavoidable costs of ethnicity : a review of evidence on health costs
74
Marginal Costs. Non-cost Costs (subtractions to get MSOC) Marginal Versus Average Costs
9
Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug resistant tuberculosis in South Africa
7
Defining Catastrophic Costs and Comparing Their Importance for Adverse Tuberculosis Outcome with Multi-Drug Resistance: A Prospective Cohort Study, Peru
17
Out-of-pocket costs and adherence to antihypertensive agents among older adults covered by the public drug insurance plan in Quebec
10
GAO ANTI-DRUG MEDIA CAMPAIGN. Aspects of Advertising Contract Mismanaged by the Government; Contractor Improperly Charged Some Costs.
10
Kentucky Drug Court Outcome Evaluation: Behavior, Costs, & Avoided Costs to Society
145
Retrospective analysis of drug utilization, health care resource use, and costs associated with IFN therapy for adjuvant treatment of malignant melanoma
11
THE COSTS AND BENEFITS
16